Alvotech rose 1.95% in after-hours trading, following the appointment of Patrik Ling as VP of Investor Relations Scandinavia. Ling brings over 25 years of experience in the life-science industry, most recently serving as Senior Equity Analyst at DNB Carnegie, covering life science companies, including Alvotech. This strategic hire is expected to enhance the company's investor relations and market presence.
Comments
No comments yet